HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait.

Abstract
The hemoglobinopathies, disorders of hemoglobin structure and production, protect against death from malaria. In sub-Saharan Africa, two such conditions occur at particularly high frequencies: presence of the structural variant hemoglobin S and alpha(+)-thalassemia, a condition characterized by reduced production of the normal alpha-globin component of hemoglobin. Individually, each is protective against severe Plasmodium falciparum malaria, but little is known about their malaria-protective effects when inherited in combination. We investigated this question by studying a population on the coast of Kenya and found that the protection afforded by each condition inherited alone was lost when the two conditions were inherited together, to such a degree that the incidence of both uncomplicated and severe P. falciparum malaria was close to baseline in children heterozygous with respect to the mutation underlying the hemoglobin S variant and homozygous with respect to the mutation underlying alpha(+)-thalassemia. Negative epistasis could explain the failure of alpha(+)-thalassemia to reach fixation in any population in sub-Saharan Africa.
AuthorsThomas N Williams, Tabitha W Mwangi, Sammy Wambua, Timothy E A Peto, David J Weatherall, Sunetra Gupta, Mario Recker, Bridget S Penman, Sophie Uyoga, Alex Macharia, Jedidah K Mwacharo, Robert W Snow, Kevin Marsh
JournalNature genetics (Nat Genet) Vol. 37 Issue 11 Pg. 1253-7 (Nov 2005) ISSN: 1061-4036 [Print] United States
PMID16227994 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobin, Sickle
Topics
  • Africa South of the Sahara (epidemiology)
  • Animals
  • Child
  • Cohort Studies
  • Hemoglobin, Sickle (genetics)
  • Heterozygote
  • Humans
  • Incidence
  • Kenya (epidemiology)
  • Malaria, Falciparum (epidemiology, genetics, prevention & control)
  • Plasmodium falciparum (growth & development)
  • Sickle Cell Trait (epidemiology, genetics)
  • alpha-Thalassemia (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: